nQ Medical is a digital therapeutics company addressing neurocognitive and neuromotor disorder via 24/7, passive data collection via personal devices. It is a frictionless, non-invasive, early detection, remote disease progression monitoring, and therapeutic measurement modality. nQ uses an artificial intelligence company to develop computational biomarkers that have been proven in five years of clinical trials to substantially change the way disease is managed for a wide range of neuromotor and neurocognitive disorders (Alzhemer's, Parkinson's, Multiple Sclerosis, ALS, concussion, et al. The platfomr focuses on analysis of user interaction with common electronic devices to capture functional decline related to neurodegenerative disorders. The fine control of typing and touch screen kinematics together with the frequent use of electronic devices allows for precise monitoring of small changes in neurodegeneration that frequently go unnoticed by clinicians. nQ allows for early detection of disease, 24/7, passive, at home, remote monitoring of disease progression and the measurement of impact of therapy at a fraction of the cost of current gold standards. There is no required task. Just use your device as your would normally use it. Of note, as one of the company's medical advisors, Zoltan Mari, MD, of the Cleveland Clinic, so aptly quoted: "As important as it is to fund novel compounds for treating diseases, it is also important to set the stage for maximum impact when those compounds are discovered and approved for use. It is impossible to find a cure without early detection. That's why drug candidates fail. When the FDA puts its stamp on the first disease modifying drugs, such early detection technologies will be instantly necessary." He goes on to state further: "We also need a disease progression marker. Nothing so far has managed to do very well (while being profoundly expensive). Much of our research and clinical interest is turning toward disease progression. All efforts should focus on readying and perfecting early detection tools and building effective, reliable, inexpensive ways of tracking disease and the impact of therapy over time.” nQ is that early detection, disease progression computational biomarker.

An automated Early Warning System that notifies clinicians about patients whose conditions may be worsening. Using artificial intelligence and other analytical techniques, it continuously analyzes maternal vital signs, fetal heart rate, contractions and labor progression. PeriWatch Vigilance provides 4 or 12 hour trended overviews and notifications for breached parameters. It automates the Oxytocin Checklist without requiring user input.This AI software solution can be used to help standardize clinical interpretation, within your unit and across any healthcare enterprise. As an early warning system, it can help clinicians intervene sooner, potentially improving clinical outcomes for moms and babies.

PeriGen offers innovative perinatal software solutions that incorporate advanced statistical analysis features to enhance clinical efficiency and standardization of care during childbirth. Led by skilled OB practitioners and IT visionaries, PeriGen has created the PeriWatch® platform to provide consistent analysis and efficient display of complex data in real-time to promote better human recognition and communication about impending problems during labor. With PeriWatch®, clinicians can spend more time on direct patient care and less time on manual calculations and data manipulation. To learn more, visit www.perigen.com; follow us on Twitter, LinkedIn, YouTube, and Facebook; or call 984.208.4250 or email.

PeriWatch Vigilance is an automated early warning system that overlays any EFM to notify clinicians when a patients condition may be worsening. It can be used with PeriGen's PeriWatch (Fetal Surveillance and Documentation) or other Electronic Fetal Monitoring systems.

**Maternal AND Fetal Dyad** Complement your existing Early Warning criteria (MEWS, SEWS, MEOWS, and MEWTS) with early warning for mom AND baby. **Automated Real Time Notifications** Automated, enterprise configurable, immediate notifications with no user validation required. The enhanced, automated surveillance is constantly browsing for abnormalities that may otherwise go unnoticed. **No "Rip and Replace"** Maintain your current system and workflows. Comprehensive ADT/HL7 interfacing with all industry standard EHRs and EFMs. **Standardized, Objective Feedback** “Always On” continuous surveillance and analysis provides a pillar of effective clinical decision support. Incorporates NICHD definitions to describe maternal/fetal physiological state. **Superior Trending Capabilities** Includes 4 or 12 hour trended overview and automated Oxytocin Checklist. **Single click access for rapid analysis and intervention: **FHR pattern analysis, Oxytocin Checklist, Labor Progression Curve, Maternal Vitals